Poland Radiotherapy Market Report 2022 to 2030

Poland Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Poland Radiotherapy Market will reach a value of $xx Mn from $40 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Poland is dominated by a few domestic players such as Elekta Poland, Sun-Nuclear Poland, and Mirion Technologies Poland. The radiotherapy market in Poland is segmented into different types, technologies, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Poland Radiotherapy is increasing due to the rise in cancer cases in the country.

ID: IN10PLPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Poland AUTHOR: Dr. Vishwa Modhia

Buy Now

Poland Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Poland Radiotherapy Market will reach a value of $xx Mn from $40 Mn in 2022, growing at a CAGR of xx% during 2022-2030.

Poland is a high-income, developed country in Central Europe bordered by Belarus, the Czech Republic, Germany, Lithuania, Russia, Slovakia, and Ukraine. Cancer has a large impact on public health in Poland, influencing healthcare costs, burdening cancer survivors and their families, and remaining one of the leading causes of death. In 2019, there were 171,218 new cancer cases (85,559 men and 85,659 women) and 100,324 cancer deaths in Poland (54,370 among men and 45,954 among women).

Cancer was the second leading cause of death in Poland over the last decade, accounting for more than one-fourth of all male and female deaths. The Polish National Cancer Registry (PLCR) collects, preserves, and manages data on all cancer cases diagnosed in the Polish population. The PLCR, which covers 38 Mn individuals, provides critical information on cancer epidemiology in Central Europe. Poland's government spent 6.5% of its GDP on healthcare in 2020.

Poland Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

FLASH radiotherapy (RT), a new strategy in radiation therapy, involves delivering ultra-high dose rate radiation to the target. In 2015, a quick pathway for cancer patients was introduced as part of a package of measures to reduce wait times for diagnostic testing and specialist visits. Cancer treatment in Poland is expected to cost $2.6 Bn by 2020, according to the Polish government. The last seven years have seen the establishment of 16 regional oncology centres throughout all voivodeships. In Poland in December 2012, there was 119 external beam radiation therapy equipment, for a ratio of one device for every 323.8 thousand patients. These aspects could boost Poland's, Radiotherapy Market.

Market restrains.

Ukraine's crisis impacts not only the country itself but also countries where many Ukrainian refugees seek sanctuary, such as Poland. Despite recent advances in cancer treatment in Poland, the system has limitations. The Polish National Cancer Registry (PNCR) is the country's only legally mandated source of cancer incidence and prevalence data, recording both adult and paediatric malignancies. These factors may deter new entrants into the Poland Radiotherapy Market.

Competitive Landscape

Key Players

Elekta Poland - a subsidiary of Elekta, a Swedish company that specializes in radiation therapy, radiosurgery, and brachytherapy equipment
Varian Medical Systems Poland - a subsidiary of Varian Medical Systems, a US-based company that develops and manufactures equipment for cancer treatment, including radiation therapy
Sun-Nuclear Poland - a subsidiary of Sun Nuclear Corporation, a US-based company that provides quality assurance tools for radiation therapy
PTW-Freiburg Poland - a subsidiary of PTW-Freiburg GmbH, a German company that produces dosimetry equipment for radiation therapy
Mirion Technologies Poland - a subsidiary of Mirion Technologies, a US-based company that produces radiation detection and measurement equipment, including for use in radiation therapy

Healthcare Policies and Reimbursement Scenarios

In Poland, radiotherapy is regulated by the Polish Nuclear Agency (PAA), which is responsible for regulating the use of ionizing radiation in all areas, including medicine. The PAA sets standards for the use of ionizing radiation and oversees the safety of radiation sources and practices. Radiotherapy is reimbursed by the National Health Fund (NFZ), which is a government-funded health insurance scheme that covers the majority of the costs of radiotherapy treatments.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.